Testosterone Potentiation of Ionophore and ADP Induced Platelet Aggregation : Relationship to Arachidonic Acid Metabolism

 

PDF Download Buy Article Permissions and Reprints

Summary

The role of arachidonic acid oxygenated products in human platelet aggregation induced by the ionophore A23187 was investigated. The ionophore produced an increased release of both saturated and unsaturated fatty acids and a concomitant increased formation of TxA₂ and other arachidonate products. TxA₂ (and possibly other cyclo oxygenase products) appears to have a significant role in ionophore-induced aggregation only when low concentrations (<1 μM) of the ionophore are employed.

Testosterone added to rat or human platelet-rich plasma (PRP) was shown previously to potentiate platelet aggregation induced by ADP, adrenaline, collagen and arachidonic acid (1, 2). We show that testosterone also potentiates ionophore induced aggregation in washed platelets and in PRP. This potentiation was dose and time dependent and resulted from increased lipolysis and concomitant generation of TxA₂ and other prostaglandin products. The testosterone potentiating effect was abolished by preincubation of the platelets with indomethacin.

• References

• 1 Johnson M, Ramey E, Ramwell PW. Androgen-mediated sensitivity in platelet aggregation. Am J Physiol 1977; 232 (04) H381-H385
  PubMedGoogle Scholar
• 2 Johnson M, Ramey E, Ramwell PW. Sex and age differences in human platelet aggregation. Nature 1975; 253: 355-357
  CrossrefPubMedGoogle Scholar
• 3 Charo IF, Feinman RD, Detwiler TC. Interrelations of platelet aggregation and secretion. J Clin Invest 1977; 60: 866-873
  CrossrefPubMedGoogle Scholar
• 4 Uzunova AD, Ramey ER, Ramwell PW. Arachidonate-induced thrombosis in mice: Effects of Gender or Testosterone and Estradiol administration. Prostaglandins 1977; 13: 995-1002
  CrossrefPubMedGoogle Scholar
• 5 Johnson M, Maish T, Ramey E, Ramwell PW. Prostaglandin (PG)-mediated sensitivity in androgen treated platelets. Fed Proc 1975; 34: 304
  PubMedGoogle Scholar
• 6 Minkes M, Stanford N, Chi M, Roth GJ, Raz A, Needleman P, Majerus PW. Cyclic adenosine 3’:5’-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions. J Clin Invest 1977; 59: 449-454
  CrossrefPubMedGoogle Scholar
• 7 Erman A, Raz A. Effects of bivalent cations on prostaglandin biosynthesis and phospholipase A₂activation in rabbit kidney medulla slices. Biochem J 1979; 182: 821-824
  CrossrefPubMedGoogle Scholar
• 8 Bills TK, Smith JB, Silver MJ. Metabolism of ¹⁴C-arachidonic acid by human platelets. Biochim Biophys Acta 1976; 424: 303-314
  CrossrefPubMedGoogle Scholar
• 9 Svensson J, Hamberg M, Samuelsoon B. Prostaglandin endoperoxides IX. Characterization of rabbit aorta contracting substance (RCS) from Guinea Pig lung and human platelets Acta Physiol Scand 1975; 94: 222-228
  CrossrefPubMedGoogle Scholar
• 10 Schwarzmann M, Raz A. Prostaglandin generation in rabbit kidney: Hormone-activated selective lipolysis coupled to prostaglandin biosynthesis. Biochim Biophys Acta 1979; 472: 363-369
  PubMedGoogle Scholar
• 11 Pilo R, Raz A. Aspirin inhibits Ca²⁺-stimulated fatty acid release from human washed platelets. Prostaglandins Med. 1981 in press
  PubMedGoogle Scholar
• 12 White JG, Rao GH R, Gerrard JM. Effects of the Ionophore A23187 on blood platelets. Am J Pathol 1974; 77: 135-150
  PubMedGoogle Scholar
• 13 Feinstein MB, Fraser C. Human platelet secretion and aggregation induced by calcium Ionophores. J Gen Physiol 1975; 66: 561-581
  CrossrefPubMedGoogle Scholar
• 14 Massini P, Lüscher EF. Some effects of ionophores for divalent cations on blood platelets. Biochim Biophys Acta 1974; 372:: 109-121
  CrossrefPubMedGoogle Scholar
• 15 Pickett WC, Jesse RL, Cohen P. Initiation of phospholipase A₂activity in human platelets by the calcium ion ionophore A23187. Biochim Biophys Acta 1977; 486: 209-213
  CrossrefPubMedGoogle Scholar
• 16 Lapetina EG, Chandrabose KA, Cuatrecasas P. Ionophore A23187 and thrombin-induced platelet aggregation: Independence from cyc-looxygenase products. Proc Natl Acad Sci USA 75: 818-822
  PubMedGoogle Scholar
• 17 Schoene WN, Iacono JM. The influence of phospholipase A₂on prostaglandin production in platelets. Adv Prostaglandin Thromboxane Res 1976; 2: 763-766
  PubMedGoogle Scholar
• 18 Rittenhouse SS, Deykin D. The Activation by Ca²⁺of platelet phospholipase A₂ . Biochim Biophys Acta 1978; 543: 409-422
  CrossrefPubMedGoogle Scholar
• 19 Jesse RL, Franson RC. Modulation of purified phospholipase A₂activity from human platelets by calcium and indomethacin. Biochim Biophys Acta 1979; 575: 467-470
  CrossrefPubMedGoogle Scholar
• 20 Derksen A, Cohen P. Patterns of fatty acid release from endogenous substrates by human platelet homogenates and membranes. J Biol Chem 1975; 250: 9342-9347
  PubMedGoogle Scholar
• 21 Jørgensen KA, Stoffersen E. On the inhibitory effect of albumin on platelet aggregation. Thromb Res 1980; 17: 13-18
  CrossrefPubMedGoogle Scholar
• 22 Lagarde M, Velardo B, Blanc M, Dechavanne M. Fatty acids bound to serum albumin decrease the half-life of thromboxane A₂ . Prostaglandins 1980; 20: 275-283
  CrossrefPubMedGoogle Scholar
• 23 Pearlman WH, Crepy O. Steroid-protein interaction with particular reference to testosterone binding by human serum. J Biol Chem 1967; 242: 182-189
  PubMedGoogle Scholar